Missing data in randomized controlled trials of rheumatoid arthritis with radiographic outcomes: A simulation study
โ Scribed by Baron, Gabriel ;Ravaud, Philippe ;Samson, Adeline ;Giraudeau, Bruno
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 78 KB
- Volume
- 59
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
Objective
To assess the impact, in terms of statistical power and bias of treatment effect, of approaches to dealing with missing data in randomized controlled trials of rheumatoid arthritis with radiographic outcomes.
Methods
We performed a simulation study. The missingness mechanisms we investigated copied the process of withdrawal from trials due to lack of efficacy. We compared 3 methods of managing missing data: all available data (caseโcomplete), last observation carried forward (LOCF), and multiple imputation. Data were then analyzed by classic tโtest (comparing the mean absolute change between baseline and final visit) or F test (estimation of treatment effect with repeated measurements by a linear mixedโeffects model).
Results
With a missing data rate close to 15%, the treatment effect was underestimated by 18% as estimated by a linear mixedโeffects model with a multiple imputation approach to missing data. This bias was lower than that obtained with the caseโcomplete approach (โ25%) or LOCF approach (โ35%). This statistical approach (combination of multiple imputation and mixedโeffects analysis) was moreover associated with a power of 70% (for a 90% nominal level), whereas LOCF was associated with a power of 55% and a caseโcomplete power of 58%. Analysis with the tโtest gave qualitatively equivalent but poorer quality results, except when multiple imputation was applied.
Conclusion
Our simulation study demonstrated multiple imputation, offering the smallest bias in treatment effect and the highest power. These results can help in planning trials, especially in choosing methods of imputation and data analysis.
๐ SIMILAR VOLUMES
## Abstract ## Objective To determine whether patients with undifferentiated arthritis (UA; inflammatory, nontraumatic arthritis that cannot be diagnosed using current classification criteria) benefit from treatment with methotrexate (MTX). ## Methods The PRObable rheumatoid arthritis: Methotrex
## Objective: To investigate sensitive ultrasonographic imaging methods for detection of synovial thickness and vascularity to discriminate between patients with early rheumatoid arthritis (ra) receiving infliximab + methotrexate (mtx) versus placebo + mtx over 18 weeks, and to compare the relation